The American Journal of Digestive Diseases

, Volume 14, Issue 3, pp 189–194 | Cite as

Australia antigen and the quest for a hepatitis virus

  • Alton I. Sutnick
  • W. Thomas London
  • Baruch S. Blumberg
Progress Report


Public Health Hepatitis Hepatitis Virus Australia Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    MacCallum, F. O., andMiles, J. A. Transmissible disease in rats inoculated with material from cases of infective hepatitis.Lancet 1:3, 1946.Google Scholar
  2. 2.
    von Bertok, L. Studies on the transmission of epidemic hepatitis virus to guinea pigs and rats prepared with ethionine.Z Immunitaetsforsch 125:358, 1963.Google Scholar
  3. 3.
    Deinhardt, F., Courtois, G., Dherte, P., Osterrieth, P., Ninane, G., Henle, G., andHenle, W. Studies of liver function tests in chimpanzees after inoculation with human infectious hepatitis virus.Amer J Hyg 75:311, 1962.Google Scholar
  4. 4.
    Havens, W. P., Jr., andWard, R. Failure to transmit infectious hepatitis to chimpanzees.Proc Soc Exp Biol Med 60:102, 1945.Google Scholar
  5. 5.
    Holmes, A. W., Capps, R. B., andDeinhardt, F. Experimental hepatitis in marmosets.J Clin Invest 46:1072, 1967.Google Scholar
  6. 6.
    Bearcroft, W. G. C. Hepatitis in African monkeys,Nature (London) 197:806, 1963.Google Scholar
  7. 7.
    Smetana, H. F. Experimental and spontaneous viral hepatitis in primates.Lab Invest 14:136, 1965.Google Scholar
  8. 8.
    Chang, R. S. Properties of a transmissible agent capable of inducing marked DNA degradation and thymine catabolism in a human cell.Proc Soc Exp Biol Med 107:135, 1961.Google Scholar
  9. 9.
    Chang, R. S., andHumes, M. The biological, immunological, and physicochemical characterization of a transmissible agent capable of inducing DNA and thymine degradation in cultured human cells.J Exp Med 115:937, 1962.Google Scholar
  10. 10.
    Chang, R. S., andOwens, S. Patterns of “lipovirus” antibody in human populations.J Immun 92:313, 1964.Google Scholar
  11. 11.
    Rightsel, W. A., Keltsch, R. A., Tekushan, F. M., andMcLean, I. W., Jr. Tissue-culture cultivation of cytopathogenic agents from patients with clinical hepatitis.Science 124:226, 1956.Google Scholar
  12. 12.
    O'Malley, J. P., Mayer, H. M., Jr., andSmadel, J. E. Antibody in hepatitis patients against a newly isolated virus.Proc Soc Exp Biol Med 108:200, 1961.Google Scholar
  13. 13.
    Hsiung, G. D., Isacson, P., andMcCollum, R. W. Studies of a myxovirus isolated from human blood.J. Immun 88:284, 1962.Google Scholar
  14. 14.
    Giles, J. P., Liebhaber, H., Krugman, S., andLattimer, D. Early viremia and viruria in infectious hepatitis.Virology 24:107, 1964.Google Scholar
  15. 15.
    Liebhaber, H., Krugman, S., Giles, J. P., andMcGregor, D. M. Recovery of cytopathic agents from patients with infectious hepatitis.Virology 24:109, 1964.Google Scholar
  16. 16.
    Buchner, B. K., andShreeve, M. Tissue culture isolation of transmissible agents from infectious hepatitis patients.Canad J Public Health 55:299, 1964.Google Scholar
  17. 17.
    Cole, R. A. Viral agents from patients with infective hepatitis.Aust J Exp Biol Med Sci 43:497, 1965.Google Scholar
  18. 18.
    Laszlo, J., Balint, E., Filep, V., Peter, M., Abraham, A., andAlmasi, S. Reproduction of the viruses isolated from cases of infectious hepatitis on Detroit-6 (VA) cell line.Nature (London) 207:326, 1965.Google Scholar
  19. 19.
    Kissling, R. E. “Laboratory Status of the Infectious Hepatitis Agent.” InTransmission of Viruses by the Water Route, Berg, G., Ed. Wiley, New York, 1965, p. 337.Google Scholar
  20. 20.
    Blumberg, B. S., Gerstley, Betty Jane S., Hungerford, D. A., London, W. T., andSutnick, A. I. A serum antigen (Australia antigen) in Down's syndrome, leukemia and hepatitis.Ann Intern Med 66:924, 1967.Google Scholar
  21. 21.
    Sutnick, A. I., London, W. T., andBlumberg, B. S. Australia antigen, Down's syndrome and hepatitis.J Clin Invest 46:1122, 1967.Google Scholar
  22. 22.
    Sutnick, A. I., London, W. T., Bayer, M., Gerstley, Betty Jane S., Cronlund, M. M., andBlumberg, B. S. Hepatitis and Australia antigen in Down's syndrome.Gastroenterology 54:1275, 1968.Google Scholar
  23. 23.
    Okochi, K., andMurakami, S. Observations on Australia antigen in Japanese.Vox Sang. In press.Google Scholar
  24. 24.
    Prince, A. M. An antigen detected in the blood during the incubation period of serum hepatitis.Proc Nat Acad Sci USA 60:814, 1968.Google Scholar
  25. 25.
    Prince, A. M. Relation of Australia and SH antigens.Lancet 2:462, 1968.Google Scholar
  26. 26.
    Vierucci, A. Australia antigen in hepatitis. Personal communication.Google Scholar
  27. 27.
    Walsh, J. H. Personal communication.Google Scholar
  28. 28.
    London, W. T., Sutnick, A. I., andBlumberg, B. S. Australia antigen and acute viral hepatitis.Ann Intern Med 70:55, 1969.Google Scholar
  29. 29.
    London, W. T., Sutnick, A. I., McKenna, P. J., andBlumberg, B. S. Australia antigen and post transfusion hepatitis.Transfusion 8:318, 1968.Google Scholar
  30. 30.
    Sutnick, A. I., London, W. T., Gerstley, Betty Jane S., Cronlund, M. M., andBlumberg, B. S. Anicteric hepatitis associated with Australia antigen: Occurrence in patients with Down's syndrome.JAMA 205:670, 1968.Google Scholar
  31. 31.
    Bayer, M. E., Blumberg, B. S., andWerner, Barbara. Particles associated with Australia antigen in the sera of patients with leukemia. Down's syndrome and hepatitis.Nature (London) 218:1057, 1968.Google Scholar
  32. 32.
    Millman, I., Zavatone, V. E., Gerstley, Betty Jane S., andBlumberg, B. S. Australia antigen in the nuclei of liver cells of patients with viral hepatitis detected by the fluorescent antibody technique.Nature (London). In press.Google Scholar
  33. 33.
    Neefe, J. R., Stokes, J., Jr., andGellis, S. S. Homologous serum hepatitis and infectious (epidemic) hepatitis. Experimental study of immunity and cross immunity in volunteers: A preliminary report.Amer J Med Sci 210:561, 1945.Google Scholar
  34. 34.
    Havens, W. P., Jr. Experiments in cross immunity between infectious hepatitis and homologous serum jaundice.Proc Soc Exp Biol Med 59:148, 1945.Google Scholar
  35. 35.
    Krugman, S., Giles, J. P., andHammond, J. Infectious hepatitis: Evidence for two distinctive clinical, epidemiological, and immunological types of infection.JAMA 200:365, 1967.Google Scholar
  36. 36.
    Findley, G. M., andMartin, N. H. Jaundice following yellow fever immunization.Lancet 1:678, 1943.Google Scholar
  37. 37.
    Freeman, G. Epidemiology and incubation period of jaundice following yellow fever vaccination.Amer J Trop Med 26:15, 1946.Google Scholar
  38. 38.
    Mirick, G. S., andShank, R. E. An epidemic of serum hepatitis studied under controlled conditions.Trans Amer Clin Climat Ass 71:176, 1959.Google Scholar
  39. 39.
    London, W. T., DiFiglia, Marion, Sutnick, A. I., Ziegenfuss, J., andBlumberg, B. S. Australia antigen associated hepatitis epidemic in a hemodialysis unit: The Au test.Clin Res 16:567, 1968.Google Scholar
  40. 40.
    Levene, C., andBlumberg, B. S. Additional specificities of Australia antigen and the possible identification of hepatitis carriers.Nature (London) 221:195, 1969.Google Scholar
  41. 41.
    Hampers, C. L., Prager, D., andSenior, J. R. Post-transfusion anicteric hepatitis.New Eng J Med 271:747, 1964.Google Scholar
  42. 42.
    Blumberg, B. S., Alter, H. J., andVisnich, S. A “new” antigen in leukemia sera.JAMA 191:541, 1965.Google Scholar
  43. 43.
    Blumberg, B. S., Melartin, L., Lechat, M., andGuinto, R. S. Association between lepromatous leprosy and Australia antigen.Lancet 2:173, 1967.Google Scholar
  44. 44.
    Blumberg, B. S., Gerstley, B. J. S., London, W. T., andSutnick, A. I. Down's syndrome: Two types distinguished by a serum isoantigen (Australia antigen).Ann Intern Med 66:1040, 1967.Google Scholar
  45. 45.
    Miller, D. G. “Hodgkin's Disease, Lymphosarcoma, and Chronic Lymphocytic Leukemia.” InImmunological Diseases. Samter, M., Ed. Little, Boston, 1965, p. 373.Google Scholar
  46. 46.
    Waldorf, D. S., Sheagren, J. N., Trautman, J. R., andBlock, J. B. Impaired delayed hypersensitivity in patients with lepromatous leprosy.Lancet 2:773, 1966.Google Scholar
  47. 47.
    Blumberg, B. S., Melartin, L., Guinto, R. A., andWerner, B. Family studies of a human serum isoantigen system (Australia antigen).Amer J Hum Genet 18:594, 1966.Google Scholar
  48. 48.
    Blumberg, B. S., Friedlaender, J. S., andWoodside, A. Autosomal recessive inheritance of susceptibility to infection in humans: Australia antigen and hepatitis.Proc Nat Acad Sci USA. In press.Google Scholar

Copyright information

© Hoeber Medical Division • Harper & Row, Publishers, Incorporated 1969

Authors and Affiliations

  • Alton I. Sutnick
    • 1
  • W. Thomas London
    • 1
  • Baruch S. Blumberg
    • 1
  1. 1.The Institute for Cancer Research, Fox ChasePhiladelphia

Personalised recommendations